NFKB1 and Splenomegaly: In patient-derived xenograft mouse models, the abrogation of NF-κB cascade effectors, including RelA, Myd88, and IL-1 receptor-associated kinase (IRAK) 4, consistently led to the suppression of leukocytosis, splenomegaly, and BM dysfunction [48].